75 completed. 75 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 75 | Completed 75 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow Glycerin trinitrate (GTN), Saline (NaCl 0,9 %) (placebo) - Coronary Arterial Disease (CAD), Angina (Stable) | Phase 4 | Completed | VZW Cardiovascular Research Center Aalst | 40 | 2024-07-01 | 2025-03-28 |
| Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting De-escalated Dual Antiplatelet Therapy, Dual Antiplatelet Therapy - Coronary Artery Disease, Coronary Artery Bypass Grafting | Phase 4 | Completed | China National Center for Cardiovascular Diseases | 2300 | 2023-02-14 | 2025-08-27 |
| MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon Mamba Sirolimus-Eluting PTCA Balloon, Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon - Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Phase 4 | Completed | Frisch Medical Device Private Limited | 360 | 2023-01-11 | 2026-03-11 |
| Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia Inclisiran Sodium, Placebo - Hypercholesterolemia | Phase 4 | Completed | Novartis Pharmaceuticals | 1770 | 2022-04-08 | 2026-04-14 |
| WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? Aspirin 75mg, Aspirin 20mg, Rivaroxaban 2.5 mg - Coronary Syndrome | Phase 4 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 48 | 2021-08-26 | 2026-02-20 |
| Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery Shexiang Baoxin pill（MUSKARDIA）, Placebo - Ischemia With Non-Obstructive Coronary Artery, Angina Pectoris | Phase 4 | Completed | Shanghai Hutchison Pharmaceuticals Limited | 240 | 2021-05-11 | 2024-04-23 |
| Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris Ticagrelor followed with Methoxyflurane, Ticagrelor followed with Morphine, Ticagrelor alone - Unstable Angina | Phase 4 | Completed | Collegium Medicum w Bydgoszczy | 72 | 2020-06-01 | 2024-03-12 |
| Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease Edoxaban Monotherapy, Edoxaban plus Single Antiplatelet Agent - Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Completed | Gi-Byoung Nam | 1040 | 2019-05-14 | 2024-06-10 |
| Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial) Stent implantation in the infart-related artery in patients with ST elevation myocardial infarction - Endothelial Dysfunction, Coronary Microvascular Disease | Phase 4 | Completed | Institut d'Investigació Biomèdica de Bellvitge | 60 | 2018-11-05 | 2020-10-26 |
| Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI) Prasugrel - Acute Coronary Syndrome (ACS) | Phase 4 | Completed | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | 204 | 2018-10-16 | 2021-11-12 |
| Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome Rivaroxaban 2.5 mg, Rivaroxaban 5 mg, Enoxaparin - Acute Coronary Syndrome, Myocardial Infarction | Phase 4 | Completed | Second Xiangya Hospital of Central South University | 2055 | 2018-01-15 | 2022-02-22 |
| Safety of Argatroban Infusion in Conduction Disturbances Argatroban - Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative) | Phase 4 | Completed | Tanabe Pharma GmbH | 50 | 2017-04-18 | 2025-12-30 |
| Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers оral intake of study drug capsules; study drug - Cardionat ® (trimethylhydrazinium propionate dihydrate), oral capsules 250 mg - Stroke, Not Specified as Hemorrhage or Infarction, Angina Pectoris | Phase 4 | Completed | Burnasyan Federal Medical Biophysical Center | 32 | 2016-11-01 | 2020-04-10 |
| Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine Crushed ticagrelor followed by morphine, Crushed ticagrelor, morphine,naloxone - Unstable Angina Pectoris | Phase 4 | Completed | Collegium Medicum w Bydgoszczy | 30 | 2016-10-01 | 2019-04-01 |
| Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention Topical Nitroglycerine, Topical Lidocaine - Radial Artery Spasm, Angina | Phase 4 | Completed | Aultman Health Foundation | 100 | 2016-09-01 | 2020-10-27 |
| The Effect of IV Cangrelor and Oral Ticagrelor Study Cangrelor, Ticagrelor - Acute Coronary Syndrome (ACS), High On-treatment Platelet Reactivity (HTPR) | Phase 4 | Completed | The Royal Wolverhampton Hospitals NHS Trust | 100 | 2016-07-21 | 2025-05-02 |
| Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine Crushed ticagrelor followed by morphine, Crushed ticagrelor, morphine,metoclopramide - Unstable Angina Pectoris | Phase 4 | Completed | Collegium Medicum w Bydgoszczy | 32 | 2016-07-01 | 2019-04-01 |
| Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial 3-months DAPT, 1-year DAPT - Stable Angina, Unstable Angina | Phase 4 | Completed | Seoul National University Hospital | 2173 | 2016-01-18 | 2023-01-10 |
| Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis Liraglutide - Microvascular Angina | Phase 4 | Completed | Eva Prescott | 33 | 2015-11-19 | 2018-07-11 |
| Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome Ranolazine, Placebo - Stable Angina, Metabolic Syndrome | Phase 4 | Completed | University of Florida | 33 | 2015-09-01 | 2020-04-10 |
Showing 20 of 75. Sign in to see all of them.
Angina, Unstable (28) · Angina, Stable (24) · Coronary Artery Disease (16) · Myocardial Infarction (12) · Coronary Disease (10) · Acute Coronary Syndrome (7) · Microvascular Angina (7) · Atherosclerosis (5) · Myocardial Ischemia (5) · Coronary Stenosis (4) · Non-ST Elevated Myocardial Infarction (4) · Stroke (4) · Cardiovascular Diseases (3) · Chest Pain (3)
Vascular Diseases (75) · Heart Diseases (74) · Cardiovascular Diseases (72) · Pathological Conditions, Signs and Symptoms (72) · Neurologic Manifestations (71) · Pain (71) · Signs and Symptoms (71) · Myocardial Ischemia (70) · Chest Pain (68) · Pathologic Processes (22) · Arterial Occlusive Diseases (21) · Arteriosclerosis (20) · Infarction (18) · Ischemia (18)
Ticagrelor (8) · Atorvastatin (6) · Clopidogrel (6) · Nitroglycerin (4) · Ranolazine (4) · Aspirin (3) · Morphine (3) · Prasugrel Hydrochloride (3) · Pravastatin (3) · Abciximab (2) · Angiotensin-Converting Enzyme Inhibitors (2) · Atenolol (2) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (2) · Nicorandil (2) · Rivaroxaban (2)
Collegium Medicum w Bydgoszczy (4) · Deutsches Herzzentrum Muenchen (3) · Aarhus University Hospital Skejby (2) · China Academy of Chinese Medical Sciences (2) · Foundation of Cardiovascular Research and Education Enschede (2) · Institut d'Investigació Biomèdica de Bellvitge (2) · Massachusetts General Hospital (2) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2) · Sheffield Teaching Hospitals NHS Foundation Trust (2) · Yonsei University (2) · AstraZeneca (1) · Aultman Health Foundation (1) · Azienda Policlinico Umberto I (1) · Balton Sp.zo.o. (1) · Bispebjerg Hospital (1)
South Korea (11) · China (10) · United States (10) · Poland (9) · Germany (8) · United Kingdom (8) · Netherlands (5) · Czechia (4) · Denmark (4) · Spain (4) · Brazil (3) · Bulgaria (3) · Canada (3) · Italy (3) · Norway (3)
Adnan Kastrati, MD (3) · Jacek Kubica, MD., PhD. (3) · Albert Schomig, MD (2) · Xiao-xi Du, Professor (2) · Alf-Aage R. Pettersen, M.D. (1) · Anders Galloe, MD (1) · Anna Toso, MD (1) · Arne Westheim, M.D. Ph.D (1) · Basmah Safdar, MD (1) · Bhavin Oza (1) · Bruce C Neal (1) · C. von Birgelen, MD,PhD,Prof (1) · Carisi A Polanczyk, MD, ScD (1) · Chim Lang (1)
PMID 35641327, PMID 37619976, PMID 37745109, PMID 38598970, PMID 39959922, PMID 11320360, PMID 12595860, PMID 14981009, PMID 15313949, PMID 16533938, PMID 16720691, PMID 17060377, PMID 17065671, PMID 17145253, PMID 17261652, PMID 17314342, PMID 17398308, PMID 18227366, PMID 18230778, PMID 18427132, PMID 18451347, PMID 18667204, PMID 18703471, PMID 18777490, PMID 18972097, PMID 19151200, PMID 19423946, PMID 19433695, PMID 19447387, PMID 19540640, PMID 19840579, PMID 20075143, PMID 20145342, PMID 20150324, PMID 20220183, PMID 20223369, PMID 20484828, PMID 20494902, PMID 20579539, PMID 21146654, PMID 21426546, PMID 21561896, PMID 21586690, PMID 21911339, PMID 22137075, PMID 22141572, PMID 22341737, PMID 22368281, PMID 22440219, PMID 22456695
2016 (1)